title: All clear for HIV-targeting ribozyme in phase II.
authors.forename: V
authors.initials: V
authors.lastname: Brower
authors.forename: K
authors.initials: K
authors.lastname: Chahine
authors.forename: E
authors.initials: E
authors.lastname: Dorey
authors.forename: A
authors.initials: A
authors.lastname: Dove
authors.forename: M
authors.initials: M
authors.lastname: Francisco
authors.forename: J
authors.initials: J
authors.lastname: Hodgson
authors.forename: A
authors.initials: A
authors.lastname: Michael
authors.forename: A
authors.initials: A
authors.lastname: Marshall
mesh_terms: D017322:Clinical Trials, Phase II as Topic; D015316:Genetic Therapy; D005822:Genetic Vectors; D015658:HIV Infections / Q000628:therapy*; D015497:HIV-1; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016337:RNA, Catalytic / Q000627:therapeutic use*
chemical_list: D016337:RNA, Catalytic